This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Crampton, S. L. Articles by Bhuyan, B. K. Search for Related Content PubMed PubMed Citation Articles by Crampton, S. L. Articles by Bhuyan, B. K.

Biochemical and Cellular Effects of Didemnins A and B

Cancer Research, The Upjohn Company, Kalamazoo, Michigan 49001

Didemnins are a new class of cyclic depsipeptides in which didemnin A is the major component, didemnin B the minor component, and a trace of didemnin C is present. Didemnin B was more potent than was didemnin A against B16 melanoma and P388 leukemia in vivo, and B was also approximately 20 times more cytotoxic than was didemnin A in vitro. Therefore, didemnin B was studied in greater detail for its biochemical and cellular effects. Didemnin B inhibited the in vitro growth of B16 > L1210 > V-79 cells = human foreskin fibroblast = 9L > Chinese hamster ovary cells. Didemnin B was more lethal to exponentially growing B16 cells (50% lethal dose for a 2-hr exposure, 17.5 ng/ml) than to plateau-phase cells (50% lethal dose for a 2-hr exposure, 100 ng/ml). After a 24-hr exposure, the 50% lethal dose for exponential- and plateau-phase B16 cells was 8.8 and 59.6 ng/ml, respectively. Chinese hamster ovary cells were not killed even at 25,000 ng/ml. Mitotic cells were the least sensitive to didemnin B, and cells became more sensitive as they progressed into G₁ and S phase. However, since cells in all phases were killed, didemnin B cannot be considered a phase-specific agent. Didemnin B inhibited the synthesis of protein more than that of DNA, with much less inhibition of RNA synthesis. Cell progression studies showed that high doses (300 ng/ml for 2 hr or 100 ng/ml for 24 hr) of didemnin B "froze" the cells in their respective phases with complete inhibition of cell progression or growth. At low doses (10 ng/ml for 2 hr or 3 ng/ml for 24 hr), the cells were blocked at the G₁-S border thereby increasing the percentage of G₁ cells and decreasing the percentage of S-phase cells. Cells continued to progress from S phase to G₂ + M and from G₂ + M to G₁. The cytotoxicity to different cell lines and inhibition of macromolecule synthesis by didemnin A is also reported.

¹ To whom requests for reprints should be addressed.

Received 4/13/83. Accepted 1/26/84.

This article has been cited by other articles:

				C. Gajate, F. An, and F. Mollinedo Rapid and Selective Apoptosis in Human Leukemic Cells Induced by Aplidine through a Fas/CD95- and Mitochondrial-mediated Mechanism Clin. Cancer Res., April 1, 2003; 9(4): 1535 - 1545. [Abstract] [Full Text] [PDF]